Markets

Market

News Details

(01/01/2026 19:36)

Kwality Pharmaceutic - Board Meeting Outcome for Appointment Of Mr. Preetmohinder Singh Bedi (DIN: 11452004) As Additional In

We wish to inform you that on the recommendation of Nomination and Remuneration Committee, the Board \r\nof Directors of the Company, at its meeting held today i.e. on January 01, 2026 has, inter alia, considered and \r\napproved the appointment of Mr. PreetMohinder Singh Bedi (DIN: 11452004) as Additional Independent \r\nDirector of the Company who shall hold office for a period of five (5) consecutive years with effect from \r\n01st January, 2026 to 31st December, 2030(both days inclusive) subject to approval of the shareholders \r\nof the Company.

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.